Abstract:Objective To evaluate the effect of resveratrol on inhibiting inflammatory responses of astrocytes and protecting neurons from injury in cerebral ischemic mice.Methods (1) Sixty adult male C57/BL6 mice were randomly assigned to sham-operated group,ischemic group (mice were subjected to transient global ischemia by bilateral common carotid artery occlusion after injection of 1.5％ DMSO),and resveratrol treatment group (mice were subjected to transient global ischemia after injection of 20 mg/kg resveratrol dissolved in 1.5％ DMSO),with 20 mice in each group;the neuronal damage in the ischemic mouse brains was analyzed by Cresyl Violet (CV) staining.(2) In vitro,the primary cultured astrocytes were divided into oxygen-glucose deprivation (OGD)-treated astrocytes group (DMSO was added into the culture medium of astrocytes followed by OGD treatment) and resveratrol-treated astrocytes group (DMSO and 25 μmol/L resveratrol were added into the culture medium of astrocytes followed by OGD treatment);the expressions of tumor necrosis factor (TNF)-α and interleukin (IL)-6 were analyzed by ELISA at re-oxygenation 12 h after 4 h-OGD treatment;meanwhile,the primary cultured neurons were injured by OGD treatment,and subsequently were divided into OGD-treated neurons group (neurons were incubated with culture medium of OGD-treated astrocytes) and resveratrol-treated neurons group (neurons were incubated with culture medium of resveratrol-trcated astrocytes).The neurite outgrowth and expressions of TNF-α and IL-6 in astrocytes of each group were analyzed by immunofluoresent staining,and the lactic dehydrogenase (LDH) release of OGD injured neurons was detected by LDH Kit.Results (1) CV staining showed that the degrees of hippocampal neurons injury in the resveratrol treatment group (1.50±0.34) were significantly decreased as compared with those in the ischemic group (3.17±0.31,P＜0.05).(2) ELISA showed that the expressions of TNF-α and IL-6 in the resveratrol-treated astrocytes group ([160.2±18.41] pg/mL,[241.25±42.22] pg/mL) were significantly decreased as compared with those in the OGD-treated astrocytes group ([282.4 ±17.01] pg/mL,[550.5 ±59.02] pg/mL,P＜0.05);LDH detection showed the release of LDH from the resveratrol-treated neurons (0.30±0.05) was dramatically decreased as compared with that from the OGD-treated neurons (0.62±0.08,P＜0.05);immunofluorescence staining showed that the TNF-α and lL-6 positive expressions in the resveratrol-treated astrocytes were obviously decreased as compared with those in the OGD-treated astrocytes,and the expressions of neurites of the resveratrol-treated neurons were obviously increased as compared with those in the OGD-treated neurons.Conclusion Resveratrol has neuroprotective effect on neurons in global cerebral ischemic mice,probably via down-regulating the expressions and secretion of inflammatory cytokines TNF-α and IL-6 from the astrocytes.

Effect of Celastrol on LncRNAs and mRNAs Profiles of Cerebral Ischemia-Reperfusion Injury in Transient Middle Cerebral Artery Occlusion Mice Model

Neuroprotective Effects of Celastrol on Transient Global Cerebral Ischemia Rats Via Regulating HMGB1/NF-B Signaling Pathway

Neuroprotective Effects of Celastrol on Transient Global Cerebral Ischemia Rats via Regulating HMGB1/NF-κB Signaling Pathway

Celastrol treatment protects against acute ischemic stroke-induced brain injury by promoting an IL-33/ST2 axis-mediated microglia/macrophage M2 polarization

Celastrol exerts a neuroprotective effect by directly binding to HMGB1 protein in cerebral ischemia–reperfusion

Spatial transcriptomics analysis of zone-dependent hepatic ischemia-reperfusion injury murine model

Celastrol protects against early brain injury after subarachnoid hemorrhage in rats through alleviating blood-brain barrier disruption and blocking necroptosis

Effect of dexmedetomidine on ncRNA and mRNA profiles of cerebral ischemia-reperfusion injury in transient middle cerebral artery occlusion rats model

Celastrol Pretreatment Attenuates Rat Myocardial Ischemia/ Reperfusion Injury by Inhibiting High Mobility Group Box 1 Protein Expression Via the PI3K/Akt Pathway.

Celastrol Ameliorates Neuronal Mitochondrial Dysfunction Induced by Intracerebral Hemorrhage via Targeting cAMP-Activated Exchange Protein-1

MicroRNAs Expression and Function in Cerebral Ischemia Reperfusion Injury

Celastrol alleviates secondary brain injury following intracerebral haemorrhage by inhibiting neuronal ferroptosis and blocking blood-brain barrier disruption

Celastrol exerts antiarrhythmic effects in chronic heart failure via NLRP3/Caspase-1/IL-1β signaling pathway

Identification of the Lncrna-Mirna-mrna Regulatory Network for Middle Cerebral Artery Occlusion-Induced Ischemic Stroke

Systematic Analysis of RNA Expression Profiles in Different Ischemic Cortices in MCAO Mice.

Neuroprotective Effects Of Celastrol On Transient Global Cerebral Ischemia Rats Via Regulating Hmgb1/Nf-Kappa B Signaling Pathway (Vol 14, 847, 2020)

Cerebral Ischemia-Induced Gene Expression Changes in Diabetic Mice from Acute to Subacute Stage

Effect of Resveratrol on Inhibiting Inflammatory Responses of Astrocytes and Protecting Neurons from Injury in Cerebral Ischemic Mice

Celastrol Attenuates Learning and Memory Deficits in an Alzheimer’s Disease Rat Model

Multiple protein and mRNA expression correlations in the rat cerebral cortex after ischemic injury and repair due to buchang naoxintong jiaonang (BNJ) intervention

Celastrol Attenuates Multiple Sclerosis and Optic Neuritis in an Experimental Autoimmune Encephalomyelitis Model